Ignite Creation Date:
2025-12-25 @ 4:52 AM
Ignite Modification Date:
2026-04-25 @ 4:40 PM
Study NCT ID:
NCT02907918
Status:
TERMINATED
Last Update Posted:
2021-09-29
First Post:
2016-09-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer
Sponsor:
Washington University School of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-30
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-23
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-14
First Submit QC Date:
None
Study First Post Date:
2016-09-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-08-10
Results First Submit QC Date:
None
Results First Post Date:
2021-09-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-08
Last Update Post Date:
2021-09-29
Last Update Post Date Type:
ACTUAL